On Tuesday, Advaxis, Inc. (NASDAQ:ADXS)’s shares declined -4.47%, and closed at $15.39, hitting new 52-week high of $16.45, after a clinical stage biotechnology corporation, declared that it is entering into a clinical trial partnership contract with the Radiation Therapy Oncology Group (RTOG) Foundation to evaluate the safety and efficacy of Advaxis’s lead cancer immunotherapy, ADXS-HPV (ADXS11-001), in a pivotal Phase 2/3 anal cancer trial, which will be run by NRG Oncology. ADXS-HPV is an investigational Lm-LLO immunotherapy bioengineered to generate an immune response to the HPV-associated tumor specific oncogene.
Under the projected collaboration, RTOG Foundation, through its partnership with NRG Oncology, will conduct an adequate and well-controlled Phase 2/3 clinical trial of concurrent chemotherapy of mitomycin C/5FU and radiation therapy (CCRT) contrast to CCRT combined with ADXS-HPV in the adjuvant treatment of high-risk locally advanced anal cancer.
Advaxis, Inc., a clinical stage biotechnology corporation, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. The Lm-LLO immunotherapy platform technology stimulates the immune system to induce antigen-specific anti-tumor immune responses involving innate and adaptive arms of the immune system by inhibiting the T-cells, tregs, and myeloid-derived suppressor cells, and MDSC to promote immunologic tolerance of cancer cells in the tumor.
J.C. Penney Company, Inc. (NYSE:JCP)’s shares dropped -4.41%, and settled at $8.88, during the last trading session on Tuesday.
Since 2014, more than 75 JCPenney home products have earned the prestigious Good Housekeeping Seal, the most of any other retailer. From curtains to bedding to cookware and small electrics, the Seal can be found in over a dozen home categories on private brand products counting Royal Velvet®, Cooks(TM), JCPenney Home(TM) and Liz Claiborne® Home. The most recent JCPenney recipients of the Seal comprise the newly launched Royal Velvet Signature Soft bath rug collection and solid bath towels together with the Cooks power blender, toaster oven, griddle and more.
In addition to the comprehensive product evaluation conducted by the Good Housekeeping Institute, customer reviews are an important part in the development and design of a JCPenney private brand product with the majority of feedback coming from reviews and ratings on jcpenney.com. Customers are invited to rate each product based on a five star rating system. The majority of private brand products have received five stars, demonstrating customers` satisfaction related to quality, design, durability and value. JCPenney product integrity teams review regular reports of product ratings to make adjustments based on specific customer feedback.
J. C. Penney Corporation, Inc., through its partner, J. C. Penney Corporation, Inc., sells merchandise through department stores in the United States. The corporation sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings, in addition to provides various services, counting styling salon, optical, portrait photography, and custom decorating.
At the end of Tuesday’s trade, Qorvo, Inc. (NASDAQ:QRVO)’s shares dipped -4.29%, and closed at $73.23, as a leading provider of RF solutions for mobile, infrastructure and aerospace/defense applications, on March 26, declared a new gallium arsenide (GaAs) pseudomorphic high electron mobility transistor (pHEMT) process technology that provides higher gain/bandwidth and lower power consumption than competing semiconductor processes. Qorvo’s new TQPHT09 is a 90 nm pHEMT process that supports Qorvo’s next-generation optical product portfolio. Coupled with Qorvo’s industry-leading reliability, this new process is ideal for next-generation high frequency, high performance amplifiers required for 100G+ linear applications.
Manufactured in Qorvo’s industry leading GaAs fabrication facility in Richardson, Texas, TQPHT09 is the newest offering in the Corporation’s well-established pHEMT process portfolio. Qorvo’s TQPHT09 serves as the basis for several new optical modulator driver products counting the TGA4960-SL, the Corporation’s most advanced quad-channel 100G modulator driver. The TGA4960-SL is accessible in the CFP2 form factor for Metro and long haul applications, and is also well suited for upgrading the 100G linear dual-channel drivers for line card applications. It is optimized for high performance, low power dissipation and high channel-to-channel isolation, and is packaged in a 14.0 x 8.0 x 2.6 mm SMT module, the smallest footprint in the industry.
Qorvo, Inc. provides technologies and radio frequency solutions for mobile, infrastructure, and aerospace/defense applications in the United States and internationally. The corporations product line comprises amplifiers, control products, discrete transistors and ICs, filters and duplexers, frequency converters, integrated modules, optical components, oscillators, passives, and switches.
Omega Healthcare Investors Inc. (NYSE:OHI), ended its Tuesday’s trading session with -4.05% loss, and closed at $40.24, as on April 1, a real estate investment firm and Aviv REIT, Inc. (NYSE:Aviv) declared the completion of Omega’s attainment of all of the outstanding shares of Aviv in a stock-for-stock merger, forming a combined corporation with equity market capitalization of about $7.8 billion and a total market capitalization of about $11.1 billion. The combined corporation will be the premier publicly traded real estate investment trust (REIT) focused principally on skilled nursing facilities (SNFs), with a diversified portfolio of investments counting over 900 properties located in 41 states and operated by 81 different operators.
Under the terms of the merger contract, each outstanding share of Aviv ordinary stock was converted into 0.90 of a share of Omega ordinary stock. In connection with the merger, Omega issued about 43.9 million shares of ordinary stock to former Aviv stockholders and holders of certain vested equity incentive awards of Aviv. On a fully diluted basis following the closing of the merger transaction, legacy Omega stockholders own about 72% of the combined corporation, and former Aviv stockholders, together with the limited partners of Aviv Healthcare Properties Limited Partnership, beneficially own about 28% of the combined corporation.
Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. was founded in 1992 and is based in Maryland, United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
